Résultat pour le terme : biotechnology
2 Terrence Kenakin nouvel essai blog neomed 2

(audio-EN) You thought you knew everything about receptors? You may learn a new concept with Terrence Kenakin

Montreal (QUEBEC) – Dr Terrence Kenakin, professor at the department of pharmacology at the University of North Carolina’s School of Medicine, explains how the concept of receptors has evolved over the last 10 years and the implications for drug discovery. It was the topic of a recent conference he gave at the NEOMED Institute. “For […]

Thrasos Therapeutics monte blog

(audio) Kidney diseases: a $21M series D financing for Thrasos Therapeutics!

Montreal (Canada) : This week, Thrasos Therapeutics, headquartered in the NÉOMED Institute, raised a $21 million series D financing lead by BDC Capital, a new investor, and SR One. Other current investors (Advanced Technology Ventures, Fonds de solidarité FTQ, Lumira Capital, MP Healthcare Venture Management, Pappas Ventures and SW Co) also participated in the operation. […]

anthony cheung essai 1

(audio-EN) DNA-based therapeutics: enGene successfuly raises CAD $13.5 million

Montreal (Quebec) – enGene, a Montreal-based biotechnology company, has just raised CAD $13.5 million in a Series B investment round led by Forbion Capital Partners, with participation of Lumira Capital and new investors Quebec’s Fonds de solidarité FTQ and Pharmstandard International. Inventor of a disruptive technology based on the idea of turning the gut into […]

edwards blog neomed test 3

(audio-EN) Dr. Aled Edwards explains why it is important to research on less well-studied proteins

Montréal (QUÉBEC) – Dr. Aled Edwards, founding CEO of the Structural Genomics Consortium (SGC) and professor at the University of Toronto, gives us a snapshot on his recent conference at the Neomed Institute where he spoke about the uncommon mission of the SGC. « In order to discover new aspects of medicine, we need to research on less well-studied […]